SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Breaks Above Two Hundred Day Moving Average – Time to Sell?

SPDR S&P Biotech ETF (NYSEARCA:XBI)’s stock price passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $144.38 and traded as high as $157.82. SPDR S&P Biotech ETF shares last traded at $156.81, with a volume of 8,367,965 shares trading hands.

SPDR S&P Biotech ETF Stock Down 2.0%

The company has a market capitalization of $10.23 billion, a P/E ratio of 11.47 and a beta of 0.84. The stock has a fifty day simple moving average of $158.19 and a 200-day simple moving average of $144.62.

Institutional Trading of SPDR S&P Biotech ETF

Several large investors have recently added to or reduced their stakes in XBI. Axiom Investment Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 1st quarter worth approximately $26,000. Financial Life Planners acquired a new stake in SPDR S&P Biotech ETF during the 1st quarter valued at $27,000. Angeles Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at $28,000. SHP Wealth Management bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $31,000. Finally, Greykasell Wealth Strategies Inc. acquired a new position in SPDR S&P Biotech ETF in the fourth quarter worth $35,000.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.